Navigation Links
SkelRegen Welcomes Director of Scientific Affairs to Management Team
Date:4/23/2013

WEST CHESTER, Pa., April 23, 2013 /PRNewswire/ -- SkelRegen, LLC, the leader in small molecule musculoskeletal tissue regeneration and the first to identify multiple small molecules that are osteoinductive and target different aspects of the musculoskeletal tissue formation pathway, today announced the hire of John M. Wozney, Ph.D. as Director of Scientific Affairs and Co-Owner. In his role at SkelRegen, Wozney will set experimental design and direction; lead collaboration with development partners; build alternative R&D pathways; and optimize project quality, cost and time variables.  

Wozney is an internationally recognized expert in the key-signaling molecules involved in the growth and maintenance of bone and soft tissues called bone morphogenetic proteins (BMPs), and musculoskeletal biology. He joins the SkelRegen team from the Genetics Institute (acquired by Wyeth and subsequently Pfizer), where he conducted research leading to the identification of BMP. He then played a key role in the commercialization of a genetically engineered protein (rhBMP-2) and the development of a local delivery system as an innovative bone-inductive therapeutic, which has found widespread use in orthopaedics.

In his role at SkelRegen, Wozney brings more than 25 years' experience in the pharmaceutical industry and scientific leadership to help grow the company as it leads the way in small molecule musculoskeletal tissue regeneration. "John brings a unique set of skills, experience and perspective to our business and we are delighted to have him join the team," said Stephen R. La Neve, SkelRegen's Co-Founder and CEO. "His accomplishments, reputation and understanding of our business will help SkelRegen bring our game-changing technologies to the bedside, and strengthen our business of small mol
'/>"/>

SOURCE SkelRegen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Chesapeake Urology Associates Welcomes Dr. Anup R. Shah
2. Paradigm Spine Welcomes Hallett Mathews, MD, MBA As Its Executive Vice President & Chief Medical Officer
3. Sequenom Welcomes Myla Lai-Goldman, M.D., To Board Of Directors
4. Thomson Reuters Welcomes Inova Software to Its Partner Ecosystem for Life Sciences
5. Draeger Welcomes NIOSH Investigation Report
6. Oriel STAT A MATRIX Welcomes New Global Practice Head for Medical Devices and Life Sciences
7. Global BioClinical Welcomes Jennifer Maas as Senior Consultant
8. SOCMAs Bulk Pharmaceuticals Task Force Welcomes House Passage of FDA Reform Act
9. SCOLR Pharma Welcomes Clem Calabrese as Director of Field Sales
10. Venaxis Appoints SomaLogic CMO and former Pfizer Executive Stephen A. Williams, M.D., Ph.D., to Board of Directors
11. Randy Hill Appointed to Vasomedical Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)...   Surefire Medical , Inc., the developer of ... targeted delivery of embolization agents in minimally invasive direct-to-tumor ... John R. Daniels , MD of the University of ... Steven C. Katz , MD of the Roger ... Board (SAB).    "The role of the ...
(Date:10/22/2014)... and AUSTIN, Texas ... and PureMHC LLC today announced they have entered ... novel antibody-based immunotherapies designed to target cancers. ... phosphorylated peptides displayed on the surfaces of tumor ... tumor targets (PTTs), derived from proteins that play ...
(Date:10/22/2014)... , Oct. 22, 2014  Regulus ... a biopharmaceutical company leading the discovery and ... announced that it has demonstrated human proof-of-concept ... clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated ... of hepatitis C virus infection ("HCV").  Interim ...
Breaking Medicine Technology:Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8
... QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) has ... significantly oversubscribed. The issue price under the Placement ... price of QRxPharma shares on 28 September 2010 of A$1.00. ... oversubscriptions from investors and increase the size of the placement from ...
... Radio (Nasdaq: SIRI ) today announced that Andrew ... Center, will host the next edition of his Doctor Radio ... on the link between early antibiotic use in children and ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080819/NYTU044LOGO ) Dr. Brotman,s guests will ...
Cached Medicine Technology:QRxPharma Limited Announces A$14 Million Placement Together With a Share Purchase Plan 2QRxPharma Limited Announces A$14 Million Placement Together With a Share Purchase Plan 3SIRIUS XM's Doctor Radio's 'The Dean's List' To Focus On Link Between Early Antibiotic Use In Children And Obesity 2SIRIUS XM's Doctor Radio's 'The Dean's List' To Focus On Link Between Early Antibiotic Use In Children And Obesity 3SIRIUS XM's Doctor Radio's 'The Dean's List' To Focus On Link Between Early Antibiotic Use In Children And Obesity 4
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, 2014 (HealthDay ... (IVF) -- the incubation of embryos in a laboratory dish ... vagina, new research suggests. Scientists from the United States ... sharply cut costs for pricey IVF procedures among certain women. ... who don,t live near big-city assisted reproduction centers, the researchers ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... officials on Monday officially tightened guidelines for health workers treating ... exposure and use of a respirator at all times. ... issue the tougher rules after two Dallas nurses contracted Ebola ... United States, Liberian national Thomas Eric Duncan. Nina Pham is ...
(Date:10/20/2014)... Dallas, Texas (PRWEB) October 20, 2014 ... is the must-have source of thousands of facts, figures ... 72 countries and 68 medical sector forecast categories the ... you with global, regional and national views on the ... future outlook. , The report gives you data for ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Allegheny General ... procedure that enables physicians to repair a damaged mitral ... MitraClip system, developed by Abbott Vascular ... a progressive and life-threatening condition in which the heart’s ... to flow backward from the heart’s left ventricle into ...
(Date:10/20/2014)... ASCNYC (ascnyc.org) is a New ... Yorkers living with HIV/AIDS and other chronic conditions ... and self-sufficiency. Each year, ASCNYC spotlights selected “Positive ... their tireless efforts. , Savills Studley ... been selected as this year’s honoree for sharing ...
Breaking Medicine News(10 mins):Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3
... that hepatitis C virus infection is a bad ... in renal transplant recipients//. ,Hepatitis C virus (HCV) ... recipients; the prevalence depends on the geographic area. ... renal transplant recipients. ,Researchers from the Armed ...
... Health Minister Anbumani Ramadoss has said that the government is ... and plans to take several steps to check female foeticide, ... ,Dr Ramadoss said that there were plans to set up ... unfortunate practice that prevails on a large scale in the ...
... is to be started by British Heart Foundation to encourage children’s ... the food which will help them to educate about healthier foods//. ... content of the foods they eat. ,More than 10% ... and 37% of children’s were not aware that cheese was made ...
... Institute of Medical Research (QIMR) have found that regular ... which are precursors to skin cancer//. The study was ... Dermatology. ,Aspirin is a cyto-oxygenase (COX) enzyme ... its expression. The COX gene is gene coded which ...
... Clinical Global Health Education was started by Bob Bollinger ... care to patients would improve only if health care ... was to provide training by John Hopkins through Global ... providers. Bollinger said, “Don’t wait for poorly funded medical ...
... Recent research demonstrates that erythrocyte sedimentation rate (ESR) ... haemoglobin concentration significantly influence ESR//. ,The erythrocyte ... the acute phase response. It is helpful in ... to treatment. It is influenced by anaemia, which ...
Cached Medicine News:Health News:John Hopkins CGHH program provides Global Health education 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: